← Back to headlines
FDA Approves Afrezza, Inhaled Insulin for Children and Adolescents with Diabetes
MannKind has announced FDA approval for Afrezza®, the first and only inhaled mealtime insulin specifically for children and adolescents aged 6 and older living with diabetes.
29 May, 16:30 — 29 May, 16:30
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
The Invention That Revolutionized Banking Hours
13m ago
Child Actors' Parents Protest AI Voice Clauses in Hasbro Contracts
25m ago
Slovakia Considers Restrictions on Social Media, Raising Concerns About Youth Addiction
25m ago